S&P 500   3,771.43 (-0.51%)
DOW   30,203.93 (-0.37%)
QQQ   281.05 (-0.38%)
AAPL   145.80 (-0.21%)
MSFT   248.33 (-0.22%)
META   138.18 (-1.50%)
GOOGL   100.81 (-0.82%)
AMZN   120.62 (-0.39%)
TSLA   239.06 (-4.16%)
NVDA   130.90 (-0.58%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.59 (-0.46%)
T   15.92 (-1.06%)
MU   54.53 (+1.06%)
CGC   3.03 (-3.50%)
F   12.43 (+0.57%)
GE   67.58 (+0.06%)
DIS   99.98 (-1.44%)
AMC   7.32 (-6.51%)
PYPL   93.77 (+1.06%)
PFE   44.09 (-0.83%)
NFLX   233.92 (-2.83%)
S&P 500   3,771.43 (-0.51%)
DOW   30,203.93 (-0.37%)
QQQ   281.05 (-0.38%)
AAPL   145.80 (-0.21%)
MSFT   248.33 (-0.22%)
META   138.18 (-1.50%)
GOOGL   100.81 (-0.82%)
AMZN   120.62 (-0.39%)
TSLA   239.06 (-4.16%)
NVDA   130.90 (-0.58%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.59 (-0.46%)
T   15.92 (-1.06%)
MU   54.53 (+1.06%)
CGC   3.03 (-3.50%)
F   12.43 (+0.57%)
GE   67.58 (+0.06%)
DIS   99.98 (-1.44%)
AMC   7.32 (-6.51%)
PYPL   93.77 (+1.06%)
PFE   44.09 (-0.83%)
NFLX   233.92 (-2.83%)
S&P 500   3,771.43 (-0.51%)
DOW   30,203.93 (-0.37%)
QQQ   281.05 (-0.38%)
AAPL   145.80 (-0.21%)
MSFT   248.33 (-0.22%)
META   138.18 (-1.50%)
GOOGL   100.81 (-0.82%)
AMZN   120.62 (-0.39%)
TSLA   239.06 (-4.16%)
NVDA   130.90 (-0.58%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.59 (-0.46%)
T   15.92 (-1.06%)
MU   54.53 (+1.06%)
CGC   3.03 (-3.50%)
F   12.43 (+0.57%)
GE   67.58 (+0.06%)
DIS   99.98 (-1.44%)
AMC   7.32 (-6.51%)
PYPL   93.77 (+1.06%)
PFE   44.09 (-0.83%)
NFLX   233.92 (-2.83%)
S&P 500   3,771.43 (-0.51%)
DOW   30,203.93 (-0.37%)
QQQ   281.05 (-0.38%)
AAPL   145.80 (-0.21%)
MSFT   248.33 (-0.22%)
META   138.18 (-1.50%)
GOOGL   100.81 (-0.82%)
AMZN   120.62 (-0.39%)
TSLA   239.06 (-4.16%)
NVDA   130.90 (-0.58%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.59 (-0.46%)
T   15.92 (-1.06%)
MU   54.53 (+1.06%)
CGC   3.03 (-3.50%)
F   12.43 (+0.57%)
GE   67.58 (+0.06%)
DIS   99.98 (-1.44%)
AMC   7.32 (-6.51%)
PYPL   93.77 (+1.06%)
PFE   44.09 (-0.83%)
NFLX   233.92 (-2.83%)
NYSE:CHE

Chemed - CHE Stock Forecast, Price & News

$446.88
-4.79 (-1.06%)
(As of 10/5/2022 01:49 PM ET)
Add
Compare
Today's Range
$443.86
$451.39
50-Day Range
$436.56
$524.08
52-Week Range
$403.00
$539.87
Volume
4,052 shs
Average Volume
81,455 shs
Market Capitalization
$6.66 billion
P/E Ratio
24.85
Dividend Yield
0.34%
Price Target
$541.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
21.4% Upside
$541.00 Price Target
Short Interest
Bearish
1.85% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
0.39mentions of Chemed in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$2.39 M Sold Last Quarter
Proj. Earnings Growth
10.20%
From $18.72 to $20.63 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.71 out of 5 stars

Medical Sector

86th out of 1,087 stocks

Home Health Care Services Industry

4th out of 9 stocks

CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

Chemed Corp.
Chemed: Dividend Insights - Benzinga
See More Headlines
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Company Calendar

Last Earnings
7/27/2022
Ex-Dividend for 9/2 Dividend
8/12/2022
Dividend Payable
9/02/2022
Today
10/05/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,137
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$541.00
High Stock Price Forecast
$541.00
Low Stock Price Forecast
$541.00
Forecasted Upside/Downside
+21.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$268.55 million
Pretax Margin
16.92%

Debt

Sales & Book Value

Annual Sales
$2.14 billion
Cash Flow
$23.36 per share
Book Value
$39.62 per share

Miscellaneous

Free Float
14,304,000
Market Cap
$6.66 billion
Optionable
Optionable
Beta
0.54

Social Links


Key Executives

  • Mr. Kevin J. McNamaraMr. Kevin J. McNamara (Age 68)
    CEO, Pres & Director
    Comp: $6.11M
  • Mr. David P. Williams (Age 61)
    Exec. VP & CFO
    Comp: $2.91M
  • Mr. Michael D. Witzeman CPA (Age 51)
    MBA, VP & Controller
    Comp: $1.06M
  • Mr. Nicholas Michael WestfallMr. Nicholas Michael Westfall (Age 43)
    Exec. VP
    Comp: $1.81M
  • Ms. Lisa A. Reinhard
    VP, Chief Admin. Officer & Assistant Sec.
  • Sherri Warner
    Director of Investor Relations
  • Mr. Brian C. Judkins (Age 41)
    VP, Sec. & Chief Legal Officer
  • Mr. Thomas C. Hutton (Age 71)
    VP & Director













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2022?

1 brokers have issued 1 year price objectives for Chemed's shares. Their CHE share price forecasts range from $541.00 to $541.00. On average, they predict the company's stock price to reach $541.00 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2022?

Chemed's stock was trading at $529.04 at the beginning of the year. Since then, CHE shares have decreased by 14.6% and is now trading at $451.67.
View the best growth stocks for 2022 here
.

Are investors shorting Chemed?

Chemed saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 263,400 shares, a drop of 7.9% from the August 15th total of 286,000 shares. Based on an average daily trading volume, of 65,000 shares, the short-interest ratio is presently 4.1 days. Approximately 1.8% of the company's stock are short sold.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings results on Wednesday, July, 27th. The company reported $4.84 earnings per share for the quarter, topping analysts' consensus estimates of $4.78 by $0.06. The firm earned $531.29 million during the quarter, compared to the consensus estimate of $538.07 million. Chemed had a trailing twelve-month return on equity of 44.64% and a net margin of 12.95%. Chemed's revenue for the quarter was down .2% compared to the same quarter last year. During the same period in the previous year, the business earned $4.60 earnings per share.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, August 5th. Investors of record on Monday, August 15th will be given a dividend of $0.38 per share on Friday, September 2nd. This represents a $1.52 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Friday, August 12th. This is a boost from the stock's previous quarterly dividend of $0.36.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.34%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.37% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY 2022 earnings guidance on Wednesday, August, 3rd. The company provided EPS guidance of $19.30-$19.50 for the period, compared to the consensus EPS estimate of $19.47. The company issued revenue guidance of -.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $451.67.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $6.73 billion and generates $2.14 billion in revenue each year. The company earns $268.55 million in net income (profit) each year or $17.98 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,137 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.